Regulated cell death pathways in doxorubicin-induced cardiotoxicity
E Christidi, LR Brunham - Cell Death & Disease, 2021 - nature.com
Doxorubicin is a chemotherapeutic drug used for the treatment of various malignancies;
however, patients can experience cardiotoxic effects and this has limited the use of this …
however, patients can experience cardiotoxic effects and this has limited the use of this …
Targeting the DNA damage response in immuno-oncology: developments and opportunities
Immunotherapy has revolutionized cancer treatment and substantially improved patient
outcome with regard to multiple tumour types. However, most patients still do not benefit …
outcome with regard to multiple tumour types. However, most patients still do not benefit …
Necroptosis-dependent immunogenicity of cisplatin: implications for enhancing the radiation-induced abscopal effect
R Luo, K Onyshchenko, L Wang, S Gaedicke… - Clinical Cancer …, 2023 - AACR
Purpose: Cisplatin is increasingly used in chemoimmunotherapy and may enhance the T
cell–dependent radiation-induced abscopal effect, but how it promotes antitumor immunity is …
cell–dependent radiation-induced abscopal effect, but how it promotes antitumor immunity is …
Vitamin A and retinoid signaling in the kidneys
KM DiKun, LJ Gudas - Pharmacology & Therapeutics, 2023 - Elsevier
Vitamin A (VA, retinol) and its metabolites (commonly called retinoids) are required for the
proper development of the kidney during embryogenesis, but retinoids also play key roles in …
proper development of the kidney during embryogenesis, but retinoids also play key roles in …
Targeting the retinoic acid pathway to eradicate cancer stem cells
G Brown - International Journal of Molecular Sciences, 2023 - mdpi.com
All-trans retinoic acid is a morphogen during embryogenesis and a teratogen. Cancer is an
error of development, and the retinoic acid receptors (RAR) for all-trans retinoic acid play a …
error of development, and the retinoic acid receptors (RAR) for all-trans retinoic acid play a …
Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy
S Yu, H Xiao, L Ma, J Zhang, J Zhang - Biochimica et Biophysica Acta (BBA …, 2023 - Elsevier
Immunogenic cell death (ICD) has been a revolutionary modality in cancer treatment since it
kills primary tumors and prevents recurrent malignancy simultaneously. ICD represents a …
kills primary tumors and prevents recurrent malignancy simultaneously. ICD represents a …
Variation in RARG increases susceptibility to doxorubicin-induced cardiotoxicity in patient specific induced pluripotent stem cell-derived cardiomyocytes
E Christidi, H Huang, S Shafaattalab, A Maillet, E Lin… - Scientific reports, 2020 - nature.com
Doxorubicin is a potent anticancer drug used to treat a variety of cancer types. However, its
use is limited by doxorubicin-induced cardiotoxicity (DIC). A missense variant in the RARG …
use is limited by doxorubicin-induced cardiotoxicity (DIC). A missense variant in the RARG …
Serine-70 phosphorylated Bcl-2 prevents oxidative stress-induced DNA damage by modulating the mitochondrial redox metabolism
SJF Chong, K Iskandar, JXH Lai, J Qu… - Nucleic acids …, 2020 - academic.oup.com
Abstract Bcl-2 phosphorylation at serine-70 (S70pBcl2) confers resistance against drug-
induced apoptosis. Nevertheless, its specific mechanism in driving drug-resistance remains …
induced apoptosis. Nevertheless, its specific mechanism in driving drug-resistance remains …
Role of necroptosis in infection‐related, immune‐mediated, and autoimmune skin diseases
L Liu, Z Tang, Y Zeng, Y Liu, L Zhou… - The Journal of …, 2021 - Wiley Online Library
Regulated necrosis, also termed necroptosis, is another programmed cell death depending
on a unique molecular pathway that does not overlap with apoptosis. Tumor necrosis factor …
on a unique molecular pathway that does not overlap with apoptosis. Tumor necrosis factor …
The multitargeted kinase inhibitor KW-2449 ameliorates cisplatin-induced nephrotoxicity by targeting RIPK1-mediated necroptosis
C Rui, S Shi, W Ren, X Qin, C Zhuang, X Chen… - Biochemical …, 2021 - Elsevier
Cisplatin (cis-dichloro-diammine platinum, CDDP) is a well-known chemotherapeutic drug
against a broad spectrum of human malignancies. However, the clinical utility of this …
against a broad spectrum of human malignancies. However, the clinical utility of this …